Meetings & Events

Hypertriglyceridemia and Cardiovascular Disease: To Treat or Not to Treat

July 21, 2020

Session Description: This session will describe the efficacy and safety of lowering triglycerides in statin-treated patients with and without CVD, including patients with type 2 diabetes.

Faculty: Savitha Subramanian, MD
University of Washington

Learning Objectives:

  1. Define Hypertriglyceridemia and explain evidence for the role of triglyceride rich lipoproteins in the development of atherosclerosis.
  2. Describe efficacy and safety in CVD outcome trials of triglyceride lowering drugs, including omega-3 fatty acids.
  3. Identify which patients might benefit from the addition of omega-3 fatty acids or fibrates to statin therapy.
  4. Discuss benefits and risks of omega-3 fatty acids in patients with type 2 diabetes.

Return to the full CEU program.

Last Updated:
EBR 2020

Assess Your Knowledge

Learn More
Assess your knowledge with 220 case-based questions that follow the ABIM's blueprint for the Endocrinology, Diabetes, & Metabolism Certification Examination. The Endocrine Board Review 12th Edition (2020) Bundle includes a printed self-study book as well as session recordings from the virtual meeting. Get yours today!

Assess your knowledge with 220 case-based questions that follow the ABIM's blueprint for the Endocrinology, Diabetes, & Metabolism Certification Examination. The Endocrine Board Review 12th Edition (2020) Bundle includes a printed self-study book as well as session recordings from the virtual meeting. Get yours today!

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!